Amgen
AMGN
1,797 hedge funds and large institutions have $104B invested in Amgen in 2018 Q3 according to their latest regulatory filings, with 112 funds opening new positions, 613 increasing their positions, 790 reducing their positions, and 64 closing their positions.
75% more first-time investments, than exits
New positions opened: 112 | Existing positions closed: 64
22% more funds holding in top 10
Funds holding in top 10: 86 → 105 (+19)
2% more funds holding
Funds holding: 1,764 → 1,797 (+33)
4% more capital invested
Capital invested by funds: $99.8B → $104B (+$3.77B)
4.63% less ownership
Funds ownership: 81.88% → 77.25% (-4.6%)
19% less call options, than puts
Call options by funds: $978M | Put options by funds: $1.21B
22% less repeat investments, than reductions
Existing positions increased: 613 | Existing positions reduced: 790
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$1.64B |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$906M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$152M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$142M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
+$123M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.87B |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$2.27B |
| 3 |
Invesco
Atlanta,
Georgia
|
-$278M |
| 4 |
ClearBridge Investments
New York
|
-$183M |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$179M |
AMGN Hedge Fund Activity: Q3 2018 in Review
1,797 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q3 2018, worth a combined $104B — up 3.8% from $99.8B a quarter earlier.
Buyers outnumbered sellers: 112 funds opened new AMGN positions and 64 closed out — a net gain of 48 holders — while 613 added to existing stakes and 790 trimmed.
The largest buyer was Capital International Investors, adding an estimated $1.64B. The largest seller was Fidelity Investments, cutting an estimated $6.87B.
- 1,797 institutional investors held Amgen (AMGN) as of Q3 2018, up from 1,764 in Q2 2018.
- Funds reported $104B of Amgen stock for Q3 2018, up 3.8% quarter-over-quarter.
- 112 funds opened new Amgen positions in Q3 2018 and 64 closed out, a net change of +48 holders.
- The largest Amgen buyer in Q3 2018 was Capital International Investors, an estimated $1.64B added.
- The largest Amgen seller in Q3 2018 was Fidelity Investments, an estimated $6.87B sold.
Based on aggregated 13F filings for Q3 2018.